INTRODUCTION
Over the past several years, increasing attention has been directed toward mild proliferative lesions in the kidneys of patients with systemic lupus erythematosus [5, 8, 9, 11, 15, 18, 19] . While some investigators have reported that mild proliferative lesions are associated with a good prognosis [5, 18] , others have described a more ominous course with progression of the histopathologic lesion and clinical deterioration [10, 19] . Several factors might account for this variability in the clinical outcome of patients with mild lupus nephritis: differences in the definition of the lesions described, different therapeutic approaches, small numbers of patients in some series, and a lack of consistent and reproducible histopathologic classification. Consequently, the clinicopathologic correlates of a mild proliferative lupus nephritis have been uncertain and require additional clarification.
In the present report, a broad definition of a mild proliferative lesion has been adopted in order to include the full spectrum of similar lesions described by others [5, 8, 11, 18, 19] . By light microscopy, the lesions included might have been termed focal proliferative, minimal changes, or pure mesangial proliferative. The purpose of this report is to emphasize the importance of the location of electron dense deposits on ultrastructural examination of these lesions. Despite similar changes on light microscopy, a progressive clinical course was seen only in patients with subendothelial deposits.
METHODS
Over an eight-year period, 72 patients with SLE have had a renal biopsy performed after informed consent had been obtained. Renal biopsy specimens were processed for light and electron microscopy as previously described [12] . A minimum of six glomeruli were present on light microscopic sections, and all the capillary loops of a composite cross section of each of at least three glomeruli were examined by electron microscopy. Careful evaluation of thin-sectioned material stained with Jones silver methenamine confirmed a generalized pattern of deposits in all the glomeruli available for light microscopy in each biopsy. Based on both light and electron microscopy, our classification of lupus nephropathy has been previously described in detail [14] .
On light microscopy, a mild proliferative lesion is defined by a slight but definite increase in the cellularity of the glomerular capillary tuft or mesangial region. The pattern of proliferation may vary from segmental changes to mild global changes which involve less than 50 percent of the glomeruli present [14] .
Twenty-three patients had a mild proliferative lesion on light microscopy. Adequate material for evaluation of light and electron microscopic changes was available in 21 of the 23 patients. These 21 patients, who were selected on the basis of renal changes on light microscopy, form the basis of this report.
All patients had clinical and serological evidence to confirm the diagnosis of systemic lupus erythematosus [6] , and none of these patients had been treated for more than four months prior to the first renal biopsy. The clinical course was reviewed and parameters of renal function, including BUN, serum creatinine, and 24-hour protein excretion, were assessed. Serum creatinine was measured by Jaffe reaction on dialyzed serum, which measures dialyzable total chromagen, and normal values in our laboratory are 0.6-1.5 mg/dl. The third component of complement (C3) was measured by the radial immunodiffusion method. Serum antibody to ds-DNA was assayed by a modification of the Farr technique [16] as previously described in detail [4] .
The renal biopsy findings of these patients with mild proliferative glomerulonephritis on light microscopy were further classified on the basis of the ultrastructural examination ( Fig. 1) . The 21 patients were divided into three groups. The first group, Group A, consisting of six patients, was characterized by the absence of electron dense deposits. The second group, Group B, was composed of five patients who had electron dense deposits limited to the mesangial area. The third group, Group C, of ten patients had subendothelial deposits along the peripheral capillary loop, usually accompanied by mesangial and sometimes subepithelial deposits. Some of the patients in this third group have been reported in a previous study of SLE nephritis associated with subendothelial deposits [13] . The patients in Groups A and B received anti-inflammatory agents and steroids for the control of the extra-renal manifestations of their SLE. A specific protocol was not used for therapy of the patients in Groups A and B and the dosage of prednisone averaged 10-15 mg/day. Patients in Group C were treated with a specific drug regimen which included prednisone and azathioprine [12, 13] . For the Group C patients, prednisone was initially started at 40-60 mg/day and tapered over the first six months to a dose of 10-15 mg/day, if the clinical manifestations of SLE had improved. Azathioprine was given in a dose of 2-3 mg/kg/ day; no attempt was made to induce leukopenia and the drug was withheld if the white blood cell count fell below 3,000 per mm3 and then restarted at a dose of 0.5 mg/kg less than the initial dose when WBC returned to normal. One of the patients in Group B and three patients from Group C were treated with cyclophosphamide (1-2 mg/kg/day). 
RESULTS
Clinical characteristics of the patients in each group are shown in Table 1 In Group B, four of the five patients have had an uncomplicated clinical course. These four patients have had stable renal function with serum creatinine less than 1.5 mg/ dl and stable or decreasing proteinuria. One (NM) of these four patients with a stable course had a second renal biopsy which demonstrated a disappearance of all electron dense deposits (Fig. 2) . One patient (JC) in Group B had a more complicated clinical course. Within five months of the initial biopsy, this patient developed increased proteinuria to greater than 5.0 gm/d, and a repeat renal biopsy revealed a membranous lesion, with mesangial and subepithelial deposits on electron microscopy. Approximately 18 months later, this patient experienced a major exacerbation of her SLE when all of her medications were discontinued. After two months of diminished renal function, her serum creatinine returned to 1.3 mg/dl while on cyclophosphamide and prednisone. A third renal biopsy continued to demonstrate only membranous changes with subepithelial and mesangial deposits on electron microsopy. No subendothelial deposits were found in any of her biopsy specimens. Overall, the patients in Group B have done reasonably well. None of the patients has developed permanent renal insufficiency and none has developed clinical evidence of a severe diffuse proliferative lupus nephritis.
In contrast, the clinical course of patients with subendothelial deposits (Group C) has been more ominous. Despite intensive therapy with prednisone and azathioprine, five patients in this group have had a progressive and deteriorating clinical course marked by increased proteinuria (greater than 3.0 gm/d) and/or reduced renal function (serum creatinine < 1.5 mg/dl). Two of these five patients died in renal failure, one is on chronic hemodialysis, and two have stabilized after substituting cyclophosphamide for azathioprine in their treatment regimen. All five of these patients have had a second renal biopsy (Fig. 2) . In each case, there has been a progression to a severe diffuse and global proliferative lesion on light microscopy and persistence of subendothelial deposits on electron microscopy. The (Fig. 2) . In each case, light microscopy continued to reveal a mild proliferative lesion. On ultrastructural examination, two patients had no deposits and two patients had only subepithelial and mesangial deposits. Subendothelial deposits were not seen on subsequent renal biopsies in any of the four patients who improved. In Group C, one-half the patients had stable or improving renal function and the other half experienced a progressive decline in their renal status. Renal deterioration was associated with persistence of subendothelial deposits on electron microscopy and progression to a diffuse and global proliferative lesion on light microscopy. Stable or improving renal function was associated with disappearance of subendothelial deposits and continued mild proliferative changes.
The initial DNA-bc was not a reliable index of the subsequent clinical course. This may be related to certain problems with the methodology of the Farr assay which have been recently reviewed by Aarden and co-workers [1, 2, 3] . These investigators emphasized that since the assay is predominantly for the detection of antibodies to double-stranded DNA that binding may be altered by factors such as molecular size, the presence of single-stranded regions, or contamination with other proteins. In recognition of these problems, we have employed a carefully standardized technique for determination of DNA-bc. Moreover, since the same technique was used throughout in the present study, the serial pattern of DNA-bc could be correlated with the serial histologic findings and patients' clinical course. As reported previously [4, 13] , DNA-bc tended to remain elevated longer in patients who subsequently had renal deterioration. Serial DNA-bc were available in 18 patients (nine in Group C and nine in Groups A and B). Five patients in Group C and nine patients in Groups A and B experienced a decrease in DNA-bc to values less than 40 percent by six months after initiation of treatment. In each case, these 14 patients had a favorable clinical outcome. Four patients in Group C had persistently elevated DNA-bc (greater than 70 percent) for as long as 24 months after onset, and all four patients experienced a deterioration in renal function.
DISCUSSION
A mild proliferative glomerulonephritis has been described in patients with SLE since the earliest classifications of lupus nephritis [7, 17] . Because of the variability in terminology between investigators, these lesions have been termed focal proliferative, minimal change, or mild mesangial proliferative. Although generally considered to carry a favorable prognosis, histologic progression and clinical deterioration have been described in some patients with these mild lesions. In fact, over the past 13 years, approximately 175 patients with mild proliferative lupus nephritis have been reported [ 19] , and histopathologic progression has been noted in one to 35 percent of reported series [19] . In the vast majority of these reports, the lesions have been examined by light microscopy alone, or insufficient data regarding ultrastructural changes are provided to allow an analysis of the importance of electron dense deposits. Several investigators have noted, however, a direct relationship between the severity of renal disease and the degree and extent of subendothelial deposits [5,9,1 1] . Only one previous report has dealt specifically with the importance of subendothelial deposits in mild proliferative lesions [19] .
The present study was designed to evaluate those factors which might allow the identification of patients with mild lupus nephritis who would be at risk for a poor outcome. In the present study, the patients in Groups A or B and those patients in Group C differ in three respects: (1) Group C patients all had subendothelial deposits on their renal biopsies, (2) Group C patients were treated more intensely with steroids and immunosuppressive drugs, and (3) histopathologic progression and permanent reduction in renal function were seen only in Group C patients. It seems unlikely that the relatively poor outcome for the Group C patients was related to either excessive or inadequate therapy. Since none of the Group C patients developed complications such as opportunistic infections which could be related to excessive drug therapy and since other patients with similar or even more extensive renal involvement have shown improvement, rather than progressive deterioration on the same drug protocol [13] , it seems unlikely that the therapeutic regimen in these patients was excessive. The rate of progression in the Group C patients (5/10) is not significantly different (X2 = 0.5; P = NS) from that in other patients with subendothelial deposits but more severe changes on light microscopy (6/21) who were treated with the same drug regimen [12, 13] . In the present report, renal deterioration occurred in five of 21 patients with mild lupus nephritis on light microscopy, which is quite similar to the incidence of progression previously reported by Ginzler in nine of 31 patients [10] , and by Zimmerman in six of 17 patients [ 19] . Therefore, it does not appear that either excessive or inadequate therapy has significantly biased clinical progression in the Group C patients since the rate of progression in this group, as a whole, is comparable with that in the current literature [10, 19] .
Although the patients who developed histopathologic progression and permanent reduction in renal function tended to have clinical evidence of more active disease at onset, the wide range of values in each group precluded the identification of those patients on clinical data alone. The degree of histopathologic changes by light microscopy was similar among all patients. The patients who progressed to a more severe diffuse and global proliferative lesion and who developed a sustained fall in renal function were characterized by: ( 1) subendothelial deposits on the initial renal biopsy, (2) persistence of the subendothelial deposits on a repeat renal biopsy 18-24 months after initiation of therapy, and (3) persistently elevated DNA-bc. Patients with a mild proliferative lesion whose renal status remained stable or improved were identified by: (1) either no deposits or only mesangial deposits on the initial renal biopsy, or (2) the disappearance of subendothelial deposits on subsequent renal biopsies, and (3) a pattern of progressive improvement in DNA-bc.
This analysis of patients with mild lupus nephritis confirms Zimmerman's observation that patients at risk for progression cannot be clearly defined by clinical features or histopathologic changes on light microscopy alone [19] . The present study provides two additional observations. First, while patients with subendothelial deposits are at greatest risk for a deterioration in renal status, not all patients with subendothelial deposits will progress, but the persistence of such deposits on subsequent renal biopsies is associated with clinical progression. Secondly, the pattern of change in DNA-bc is a helpful prognostic indicator in this group of patients with mild renal disease in a manner similar to that previously reported in patients with more severe renal lesions [13] . Patients with mild lupus nephritis on light microscopy but subendothelial deposits on ultrastructural examination require careful follow-up and may need intensive therapy to prevent progressive renal changes.
